2m 2m 2m 2m 2m 2m 2m
PROKIDNEY-A (PROK)
NASDAQ
$1.73+$0.02 (+1.40%)
Price as of Oct 02, 2026 4:42 PM EDT- $357.3MMarket Cap
- -38.49%1-Year Change
- BiotechnologyIndustry
PROKIDNEY-A (PROK)
$1.73+$0.02 (+1.40%)
PROK | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $1.71 | ||
Change | +$0.05 (+3.01%) | ||
Open | $1.66 | ||
High | $1.76 | ||
Low | $1.64 | ||
Previous Close | $1.66 | ||
Volume | 1,511,176 | ||
30-Day Average Volume | 1,676,981 | ||
1-Week Change | 1.79% | ||
1-Month Change | -7.57% | ||
1-Year Change | -38.49% | ||
3-Year Change | -62.66% | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 208.9M | ||
Total Assets | $249.0M | ||
Market Cap | $357.3M | ||
Enterprise Value | $282.4M | ||
Period: QTR TTM FY | |||
Revenue | $150,000.00 | ||
Net Income | -$28.4M | ||
Free Cash Flow | -$44.2M | ||
EBIT | -$28.4M | ||
EBITDA | -$26.7M | ||
Net Working Capital | $167.1M | ||
EPS | -$0.15 | ||
Enterprise Value/EBITDA | -11 | ||
Enterprise Value/Revenue | 1,883 | ||
P/B | -0 | ||
P/E | -11 | ||
PEG | 2 | ||
Price/Free Cash Flow | -8 | ||
Price/Operating Cash Flow | -9 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue